Prognostic Effect of Preoperative Albumin-to-Globulin Ratio in Patients with Non-Metastatic Bladder Cancer Undergoing Radical Cystectomy
Oncology · 06.02.2026 · 104 (8) · 880-890
DOI: 10.1159/000550892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 06.02.2026. Verfasst von Haruko Takada und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy, Serum Albumin, Serum Globulins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Blood-based inflammatory and nutritional biomarkers have been crucial prognostic indicators in various malignancies. This study aimed to investigate the association of preoperative biomarkers with postoperative outcome in patients with non-metastatic bladder cancer (clinical stage ≤IIIb) who underwent radical cystectomy (RC).
Methods
This study retrospectively analyzed data, including preoperative albumin-to-globulin ratio (AGR), neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein-to-albumin ratio (CAR), of 235 patients with non-metastatic bladder cancer who underwent RC at 10 Kitasato University-affiliated hospitals between 2002 and 2023.
Results
Survival analyses revealed the significant association of low AGR with poorer 5-year disease-free survival (DFS) (31% vs. 64%, p < 0.001) and overall survival (OS) (44% vs. 70%, p < 0.001). High NLR correlated with DFS (53% vs. 72%, p = 0.008) and OS (59% vs. 79%, p = 0.009), whereas high CAR was significant only for OS (39% vs. 60%, p = 0.001). Multivariable analysis demonstrated that low AGR was significantly associated with poorer DFS (hazard ratio [HR]: 1.75; 95% confidence interval [CI]: 1.02–2.98; p = 0.041) and OS (HR: 1.83; 95% CI: 1.04–3.22; p = 0.037).
Conclusion
Preoperative blood-based biomarkers may help identify patients at high risk of non-metastatic bladder cancer after RC. In particular, AGR provides a simple, inexpensive, and widely applicable tool for risk stratification and treatment planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan.
- Department of Urology, Sagamino Hospital, Kanagawa, Japan.
- Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan, ikeda.masaomi@grape.plala.or.jp.
- Department of Urology, Kitasato University Medical Center, Saitama, Japan.
- Department of Urology, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
- Department of Urology, Musashimurayama Hospital, Tokyo, Japan.
Zitieren
APA
Takada, H., Ikeda, M., Tanaka, R., Samejima, N., Harano, T., Kobayashi, S., Toyoda, M., Kawamura, M., Okuda, S., Hada, R., Shiba, I., Shiono, Y., Shimura, S., Mori, K., Hirano, S., Koguchi, D., Tsumura, H., Ishii, D., & Matsumoto, K. (2026). Prognostic Effect of Preoperative Albumin-to-Globulin Ratio in Patients with Non-Metastatic Bladder Cancer Undergoing Radical Cystectomy. Oncology, 104(8), 880-890. https://doi.org/10.1159/000550892
Vancouver
Takada H, Ikeda M, Tanaka R, Samejima N, Harano T, Kobayashi S, et al. Prognostic Effect of Preoperative Albumin-to-Globulin Ratio in Patients with Non-Metastatic Bladder Cancer Undergoing Radical Cystectomy. Oncology. 2026;104(8):880-890. doi:10.1159/000550892
BibTeX
@article{Takada2026,
author = {Takada, Haruko and Ikeda, Masaomi and Tanaka, Rena and Samejima, Noriaki and Harano, Takahiro and Kobayashi, Shinya and Toyoda, Masayoshi and Kawamura, Mizuho and Okuda, Satoshi and Hada, Risa and Shiba, Izuru and Shiono, Yutaka and Shimura, Soichiro and Mori, Kohei and Hirano, Shuhei and Koguchi, Dai and Tsumura, Hideyasu and Ishii, Daisuke and Matsumoto, Kazumasa},
title = {Prognostic Effect of Preoperative Albumin-to-Globulin Ratio in Patients with Non-Metastatic Bladder Cancer Undergoing Radical Cystectomy},
journal = {Oncology},
year = {2026},
volume = {104},
number = {8},
pages = {880--890},
doi = {10.1159/000550892}
}
EUVIMED